Albany, NY -- (SBWIRE) -- 03/13/2018 -- Global Transcriptomics Market: Brief Account
Transcriptomics incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomics market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomics solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.
View Report Preview:
In terms of end use, type of product, and technology, the global transcriptomics market could be segmented to help participants make a careful analysis and find authentic growth opportunities.
The authors of the report have taken into account all the important aspects of the global transcriptomics market in order to provide a deep insight for buyers to ensure a lasting advancement in the business.
Global Transcriptomics Market: Trends and Opportunities
The international transcriptomics market is expected to gain impetus from the increasing amount of investments directed toward research and development activities in molecular genetics. Newer innovations such as those pertaining to next-generation sequencing (NGS) and RNA interference (RNAi) have birthed as a result of the technological advancements in the international transcriptomics market. With improved precision and accuracy, these cutting-edge technologies can be put to use with a view to help researchers analyze the transcriptional activity of a vast range of diverse organisms. This will in turn assist to furnish precise outcomes and manage colossal quantities of transcriptomics data with the help of improved data analysis practices.
High cost of service on account of the dearth of trained professionals and high input cost is projected to discourage end users from opting for transcriptomics. Howbeit, cheaper and novel technologies that keep cost in view are anticipated to set the tone for the global transcriptomics market. The analysts foresee a steady growth over the forecast years on the part of the global transcriptomics market as cardiac diseases coupled with pollution-related ailments spread their presence worldwide. Biotechnology research and drug innovation actively and extensively employ transcriptomics technologies.
Global Transcriptomics Market: Geographical Study
Prophesied to register a significant CAGR for the forecast years, Asia Pacific could rely on countries such as India, Japan, and China for its strong growth in the global transcriptomics market. The region is predicted to fuel the demand in the global transcriptomics market on the back of a widespread presence of a ballooning count of biotech as well as pharma firms. This could be underpinned by the tangible economic growth and government support witnessed therein.
However, North America is envisioned to be crowned as the maximum shareholder in the global transcriptomics market. The dominance of this regional transcriptomics market could be due to the development and existence of top-tier pharmaceutical and biotechnology companies, especially in the U.S. The Middle East, Africa, Europe, and Latin America could be the other vital regions making a statement in the global transcriptomics market.
Request to view Sample Report:
Global Transcriptomics Market: Competitive Scenario
Some of the top players functioning in the global transcriptomics market are Becton, GE Healthcare, Roche Diagnostics, Agilent Technologies, and Thermo Fisher Scientific. With most end users purchasing reagents in bulk, vendors in the global transcriptomics market could be benefited with a larger revenue in the transcriptomics consumables sector. Enzymes, reagents, and assays are frequently procured for the purpose of performing various tests in the transcriptomics consumables sector.